Neem Leaf Oil Induced Cancer Cell Death in Lab Study

Researchers observed that colorectal cancer cells showed higher rates of programmed cell death when exposed to essential oil from Azadirachta indica.

Updated on Sept. 24, 2026 in Cancer

A glass pipette drips amber oil into a clear petri dish on a white laboratory bench, highlighting biochemical research.
Researchers identified that essential oil from Azadirachta indica leaf extract induced programmed cell death in colorectal cancer cells during recent laboratory testing. AI Illustration. Upload story photo >

In a new laboratory study, an essential oil extracted from the leaves of the neem tree (Azadirachta indica) triggered apoptosis, or programmed cell death, in colorectal cancer cells. This research is a preliminary investigation conducted on cultured cell lines.

Why it matters

Scientists are exploring plant-based compounds to identify potential new molecular targets for treating colorectal cancer. This work aims to establish how specific phytochemicals interact with genes to inhibit the growth of cancer cells.

A laboratory study evaluated the effects of Azadirachta indica essential oil on HT-29 colorectal cancer cells, measuring an apoptosis rate of up to 41.8% after 24 hours of exposure. These findings are preliminary and represent cell-level observations.

The players

Azadirachta indica

Also known as the neem tree, this plant is being studied for its potential medicinal properties and phytochemical profile.

The details

The essential oil appeared to work by modulating key proteins involved in the life cycle of cancer cells. Researchers noted increased activity of Caspase 3, Caspase 9, and Bax, which promote cell death, alongside a decrease in BCL-2, which helps cells survive. Molecular docking suggests that the phytochemical phytol may be the primary component interacting with hub proteins like STAT3 and NFKB1 to inhibit tumor cell proliferation.

Timeline

  1. 24 hours of incubation time for the colorectal cancer cells.

Health Landscape

This research aligns with the broader scientific effort to identify novel plant-derived compounds that can target cancer cell pathways. It contributes to the existing body of preclinical studies investigating botanical candidates for future drug development.

This finding is a preliminary laboratory result and does not change current colorectal cancer treatment protocols. Decisions regarding screening, diet, or treatment should always be made in consultation with a physician.

The takeaway

This study highlights the potential for future drug development based on chemical compounds found in neem leaves. If you are currently managing colorectal health, focus on evidence-based screening schedules and maintain an open dialogue with your doctor about any new research you encounter.

Further reading

For more information on current developments in oncological research, visit our Cancer section.

Source note: This article includes information reported by Nature.